Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
Basic and Clinical Research on RETT Syndrome and MECP2
Release Date: April 8, 2003
Announcement Number: PA-03-097
Application Receipt Date:
June 1, 2003
October 1, 2003
February 1, 2004
June 1, 2004
October 1, 2004
Funding Contact: Robert Finkelstein, Ph.D.
Program Area: Neurogenetics
Also See:
http://grants.nih.gov/grants/guide/pa-files/PAS-05-024.html
Brief Description:
Inviting research grant applications aimed at understanding or treating Rett Syndrome (RTT). The recent demonstration that
mutations in the MeCP2 gene cause most cases of RTT has created new opportunities for both basic and clinical research. Included
within the scope of this PA are developmental, molecular genetic, and pathophysiological research, therapy development projects
and clinical studies. Studies of the role of MeCP2 in basic biological processes or in the etiology of other neurological
or neurobehavioral disorders are also appropriate.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |